Apria Stock News

Apria, Inc. (NYSE:APR) SVP Celina M. Scally sold 1,274 shares of the companys stock in a transaction that occurred on Tuesday, December 14th. The stock was sold at an average price of $30.75, for a total transaction of $39,175.50. The transaction was disclosed in a document filed with the SEC, which is available at the []

Apria, Inc. (NYSE:APR) major shareholder Blackstone Inc sold 349,527 shares of the stock in a transaction on Tuesday, December 14th. The shares were sold at an average price of $29.93, for a total transaction of $10,461,343.11. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the []

First Quadrant L P CA acquired a new position in shares of Apria, Inc. (NYSE:APR) during the third quarter, Holdings Channel reports. The institutional investor acquired 1,151 shares of the companys stock, valued at approximately $43,000. Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Harbor Group []

Apria, Inc. (NYSE:APR) Director John G. Figueroa sold 4,103 shares of the firms stock in a transaction that occurred on Friday, December 3rd. The shares were sold at an average price of $30.01, for a total value of $123,131.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible []

Goldman Sachs Group Inc. purchased a new position in Apria, Inc. (NYSE:APR) during the second quarter, HoldingsChannel reports. The fund purchased 20,242 shares of the companys stock, valued at approximately $567,000. Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Bank of New York Mellon [] The post Goldman Sachs Group Inc. Invests $567,000 in Apria, Inc. (NYSE:APR) appeared first on ETF Daily News .

Apria, Inc. (NYSE:APR) EVP Robert P. Walker sold 5,421 shares of the stock in a transaction that occurred on Wednesday, December 1st. The shares were sold at an average price of $28.48, for a total value of $154,390.08. The sale was disclosed in a legal filing with the SEC, which is available at the SEC []

Aveanna Healthcare (NASDAQ:AVAH) and Apria (NYSE:APR) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership. Profitability This table compares Aveanna Healthcare and Aprias net margins, return on equity and return on []

Apria, Inc. (NYSE:APR) Investment analysts at Piper Sandler issued their FY2021 earnings estimates for Apria in a research note issued on Monday, November 29th. Piper Sandler analyst J. Garro anticipates that the company will post earnings per share of $1.74 for the year. Piper Sandler has a Overweight rating and a $40.00 price target []

Apria, Inc. (NYSE:APR) Analysts at Piper Sandler issued their Q1 2023 earnings per share (EPS) estimates for shares of Apria in a research note issued to investors on Monday, November 29th. Piper Sandler analyst J. Garro expects that the company will post earnings per share of $0.45 for the quarter. Piper Sandler has a []

Apria (NYSE:APR) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Profitability This table compares Apria and Aveanna Healthcares net margins, return on equity and return on []

Shares of Apria, Inc. (NYSE:APR) have been given an average recommendation of Buy by the seven research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among analysts that have []

Aveanna Healthcare (NASDAQ:AVAH) and Apria (NYSE:APR) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings. Institutional and Insider Ownership 68.1% of Aveanna Healthcare shares are held by institutional investors. Strong institutional [] The post Contrasting Aveanna Healthcare (NASDAQ:AVAH) and Apria (NYSE:APR) appeared first on ETF Daily News .

Apria (NYSE:APR) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, dividends, risk, valuation, earnings and institutional ownership. Profitability This table compares Apria and Aveanna Healthcares net margins, return on equity and return on []

Aveanna Healthcare (NASDAQ:AVAH) and Apria (NYSE:APR) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation. Valuation and Earnings This table compares Aveanna Healthcare and Aprias gross revenue, earnings per share (EPS) []